We are live on ! Find out more
CUAMC

China Universal Asset Management Company Portfolio holdings

AUM $1.67B
1-Year Est. Return 89%
This Fund
S&P 500
This Quarter Est. Return
+17.99%
1 Year Est. Return
+89%
3 Year Est. Return
+264.17%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.06B
AUM Growth
-$12.1M
Cap. Flow
-$142M
Cap. Flow %
-13.41%
Top 10 Hldgs %
37.54%
Holding
501
New
15
Increased
262
Reduced
172
Closed
24

Top Buys

Rank Stock Value
1
GLD icon
SPDR Gold Trust
GLD
+$6.54M
2
IAUM icon
iShares Gold Trust Micro
IAUM
+$4.59M
3
GLDM icon
SPDR Gold MiniShares Trust
GLDM
+$3.58M
4
INTU icon
Intuit
INTU
+$3.2M
5
TMUS icon
T-Mobile US
TMUS
+$2.41M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$17.2M
2
MSFT icon
Microsoft
MSFT
+$10M
3
NVDA icon
NVIDIA
NVDA
+$9.7M
4
AMZN icon
Amazon
AMZN
+$7.99M
5
AVGO icon
Broadcom
AVGO
+$6.64M

Sector Composition

Rank Sector Weight
1 Technology 38.15%
2 Healthcare 22.68%
3 Communication Services 12.64%
4 Consumer Discretionary 11.62%
5 Consumer Staples 3.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZETA icon
276
Zeta Global
ZETA
$7.17B
$341K 0.03%
22,000
-93,000
-81% -$1.24M
SRPT icon
277
Sarepta Therapeutics
SRPT
$1.94B
$338K 0.03%
19,739
+276
+1% +$11.8K
ARQT icon
278
Arcutis Biotherapeutics
ARQT
$3.3B
$336K 0.03%
23,941
+144
+0.6% +$2.02K
XNET
279
Xunlei
XNET
$316M
$306K 0.03%
+75,500
New +$350K
VERA icon
280
Vera Therapeutics
VERA
$2.16B
$302K 0.03%
12,809
+22
+0.2% +$495
VFC icon
281
VF Corp
VFC
$5.73B
$293K 0.03%
24,906
-39,000
-61% -$483K
ETNB
282
DELISTED
89bio
ETNB
$288K 0.03%
29,320
+38
+0.1% +$315
ANIP icon
283
ANI Pharmaceuticals
ANIP
$1.73B
$284K 0.03%
4,349
-16
-0.4% -$1.04K
BHVN icon
284
Biohaven
BHVN
$2.17B
$282K 0.03%
+20,000
New +$356K
EWTX icon
285
Edgewise Therapeutics
EWTX
$4.73B
$277K 0.03%
21,120
+2,127
+11% +$30.7K
JANX icon
286
Janux Therapeutics
JANX
$1.02B
$275K 0.03%
11,885
+30
+0.3% +$790
HLT icon
287
Hilton Worldwide
HLT
$72.6B
$272K 0.03%
1,021
– –
TVTX icon
288
Travere Therapeutics
TVTX
$5.86B
$264K 0.02%
17,836
+36
+0.2% +$597
TXG icon
289
10x Genomics
TXG
$7.52B
$258K 0.02%
22,313
+601
+3% +$5.48K
INVA icon
290
Innoviva
INVA
$1.5B
$253K 0.02%
12,608
+36
+0.3% +$692
CNTA
291
DELISTED
Centessa Pharmaceuticals
CNTA
$252K 0.02%
19,181
+870
+5% +$11K
IMCR icon
292
Immunocore
IMCR
$1.77B
$250K 0.02%
7,982
+35
+0.4% +$1.09K
GPCR icon
293
Structure Therapeutics
GPCR
$3.83B
$248K 0.02%
11,967
+16
+0.1% +$352
CVAC
294
DELISTED
CureVac
CVAC
$246K 0.02%
45,222
+224
+0.5% +$888
DVAX
295
DELISTED
Dynavax Technologies
DVAX
$239K 0.02%
24,118
-768
-3% -$8.09K
KNSA icon
296
Kiniksa Pharmaceuticals
KNSA
$6.1B
$235K 0.02%
8,503
+77
+0.9% +$1.96K
AUPH icon
297
Aurinia Pharmaceuticals
AUPH
$2.06B
$230K 0.02%
27,135
-413
-1% -$3.31K
MNKD icon
298
MannKind Corp
MNKD
$1.24B
$228K 0.02%
61,044
+149
+0.2% +$656
HROW icon
299
Harrow
HROW
$1.48B
$225K 0.02%
7,371
+227
+3% +$6.1K
ALV icon
300
Autoliv
ALV
$8.85B
$224K 0.02%
2,000
– –
10 11
12
13 14

Similar funds

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
JPM
JANA Partners Management New York $1.67B AUM 1.66% 1-Year Est. Return
CPO
Cerity Partners OCIO New York $1.67B AUM 13.22% 1-Year Est. Return
LCI
L1 Capital International Sydney NSW 2000, Australia $1.68B AUM 9.83% 1-Year Est. Return
GWM
GDS Wealth Management Flower Mound, Texas $1.66B AUM 18.11% 1-Year Est. Return
JIP
Jaffetilchin Investment Partners Tampa, Florida $1.68B AUM 22.81% 1-Year Est. Return
RMC
Ribbit Management Company Palo Alto, California $1.68B AUM 40.61% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return

China Universal Asset Management Company's Q2 2025 Portfolio in Review

As of Q2 2025, China Universal Asset Management Company held 501 positions worth $1.06B, down 1.1% from $1.07B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

China Universal Asset Management Company withdrew a net $142M in Q2 2025, closing 24 positions and reducing 172 holdings. Its most notable exit was Intra-Cellular Therapies Inc., an estimated $2.81M position sold in full.

By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 37% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, China Universal Asset Management Company opened a new position in Tencent Music worth $1.66M.

  • China Universal Asset Management Company's largest Q2 2025 buy was Tencent Music: 85,000 shares worth $1.66M.
  • China Universal Asset Management Company added most to SPDR Gold Trust in Q2 2025, an estimated $6.54M increase.
  • China Universal Asset Management Company's biggest Q2 2025 reduction was Apple, cutting an estimated $17.2M.
  • China Universal Asset Management Company fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $2.81M.
  • China Universal Asset Management Company's ten largest holdings make up 38% of its $1.06B portfolio in Q2 2025.
  • China Universal Asset Management Company opened 15 new positions and closed 24 in Q2 2025.
  • China Universal Asset Management Company's portfolio value fell 1.1% quarter-over-quarter to $1.06B.

Based on China Universal Asset Management Company's 13F filing for Q2 2025, filed 28 Aug 2025.